OR WAIT null SECS
December 10, 2021
Guide addresses challenges of applying GMPs to autologous cell therapy manufacturing.
December 09, 2021
Sanofi’s acquisition of Origimm Biotechnology will add to its pipeline of vaccine candidates for treating acne.
December 03, 2021
Fujifilm’s center adds local support in Suzhou, China for cell culture media optimization.
Increased patient-centricity and alternative dosage forms require careful consideration when selecting the best taste-masking approach.
December 01, 2021
CordenPharma will build a clinical trial development facility for manufacture of oral solid dosage drug products at its Plankstadt facility near Heidelberg, Germany.
November 29, 2021
Samsung Biologics, GreenLight Biosciences, and Environmental Impact Acquisition Corp. have partnered to advance GreenLight’s mRNA COVID-19 vaccine candidate.
The companies are testing their existing vaccines against the new variant of concern and are pursuing variant-specific versions.
The Comirnaty vaccine received a positive opinion from the EMA’s CHMP for children five to under 12 years of age.
November 19, 2021
Novavax has announced that EMA has started its review of a conditional marketing authorization application for its COVID-19 vaccine, NVX-CoV2373.
November 17, 2021
Pfizer’s PAXLOVID oral solid-dosage treatment is designed to combat SARS-CoV-2 in high-risk patients at the first sign of infection.